Molecular Assemblies is developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The Company’s patented full enzymatic synthesis technology, based on making DNA the way nature makes DNA, can produce long, high quality, sequence-specific DNA reliably, affordably, and sustainably. Molecular Assemblies’ FES technology will enable the reading and writing of DNA for industries, including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics.
Press Release Coming on Tuesday